Влияние расширения рекомендаций по лечению гепатита В: моделирование и анализ экономического воздействия
Summary Antiviral treatment in patients with chronic hepatitis B (CHB) may decrease the risk of hepatocellular carcinoma (HCC) and death. However, only 2.2% of CHB patients receive antiviral treatment globally. The complexity and strictness of the current clinical practice guidelines may limit expanding the treatment coverage for CHB. We examined the impact of expanding treatment […]
Russian 
English 
Spanish 
French 
Arabic